Triple

Target class: COPD maintenance therapy
Context triple: [Symbicort, instanceOf, COPD maintenance therapy]

• A. chronic disease
  A chronic disease is a long-lasting health condition that typically progresses slowly over time and often requires ongoing medical management rather than a one-time cure.
• B. disease-modifying therapy
  A disease-modifying therapy is a treatment that alters the underlying course or mechanisms of a disease to slow its progression, reduce long-term damage, or change its overall outcome rather than just alleviating symptoms.
• C. nicotine replacement therapy company
  A nicotine replacement therapy company develops, manufactures, and markets products such as patches, gums, lozenges, and inhalers designed to help individuals reduce or quit smoking by providing controlled doses of nicotine without the harmful components of tobacco smoke.
• D. tobacco control measure
  A tobacco control measure is a policy, regulation, or intervention designed to reduce tobacco use, exposure to tobacco smoke, and the associated health and social harms.
• E. nicotine replacement therapy brand
  A nicotine replacement therapy brand is a labeled product line that delivers controlled doses of nicotine through non-tobacco forms (such as patches, gums, or lozenges) to help individuals reduce withdrawal symptoms and quit smoking.
• F. None of above. chosen